Plus, news about BrainEver, Clinigen, MaaT Pharma, Dyadic and Nektar Therapeutics:
Cloudbreak Pharma shares fall in Hong Kong debut: The ophthalmology biotech, which has offices in California and China, went public on the Hong Kong ...
↧